Semaglutide Circus: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists to Treat Addiction

Product not yet rated

  • Register
    • Non-Member - $39
    • Regular Member - $29
    • Retired - $29
    • Early Career Physician - $29
    • Resident - $19
    • Student - $19
    • Associate - $19
    • ASAM Staff - Free!
    • International Member - $29
    • Emeritus Member - $29
    • Provisional Member - $29
    • Fellow Member - $29
    • Honorary Member - $29
    • CRT Member - $29
Logo for ASAM's 55th Annual Conference

Semaglutide Circus: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists to Treat Addiction

Recorded: Thursday, April 4, 2024 to Sunday, April 7, 2024
On-Demand Session

Overview

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the preclinical evidence in favor of repurposing GLP-1 receptor agonists as possible addiction pharmacotherapies.

Anecdotal reports of the efficacy of semaglutide and other Glucagon-Like Peptide-1 (GLP-1) receptor agonists as medical therapies for obesity have garnered widespread public attention, engendering ethical debates and leading to worldwide drug shortages. This focus session will provide a deep dive into GLP-1 receptor agonists to separate fact from fiction, including the exciting evidence for possible repurposing of GLP-1 receptor agonists to treat addictive disorders.

The target audience for this Intermediate level session includes physicians, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.

This session addresses the following ACGME Competencies: Medical Knowledge, Systems-based Practice

This session addresses the following ICPE Competencies:Values and Ethics, Roles and Responsibilities

Learning Objectives

Upon completion, learners will be able to:

  1. describe the preclinical evidence in favor of repurposing GLP-1 receptor agonists as possible addiction pharmacotherapies
  2. recount the clinical trials studying the safety and efficacy of GLP-1 receptor agonists for addiction
  3. consider methods for providing fair and just access to new, expensive medications like GLP-1 receptor agonists to all segments of society

Registration Rates

Rate DescriptionRate
ASAM Member$29
Non-Member$39
Associate Member$19
Resident Member*$19
Student Member*$19

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 05/06/2024 - 04/06/2027

User Access Closed: 05/06/2027

Session Instructions

  1. Click on the Contents tab to watch the on-demand recording.
  2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
  3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
  4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Stephanie T. Weiss

MD, PhD

Stephanie T. Weiss, MD PhD is the staff Research Physician serving the Translational Addiction Medicine Branch (TAMB) of the NIDA Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree from Cleveland Clinic Lerner College of Medicine. She is board certified in emergency medicine and medical toxicology, a subspecialty that cares for patients with poisonings, environmental exposures, and overdoses. She subsequently completed a second fellowship in addiction medicine research and was selected to participate in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA. Dr. Weiss assumes responsibility for providing optimal, safe, and ethical care to study participants and clinical support toward the TAMB mission conducting inpatient and outpatient proof-of-concept human laboratory studies. Her research interests include novel psychoactive substances, medication misuse, and improving interpretation of urine drug testing.

No relevant financial disclosures.

Jeffrey Brent, MD, PhD

Distinguished Clinical Professor

University of Colorado School of Medicine

Jeffrey Brent, M.D., Ph.D., is a Distinguished Clinical Professor of Medicine and Emergency Medicine at the University of Colorado School of Medicine. He currently serves as co-Principle Investigator of the Toxicology Investigators Consortium, an NIH, FDA, and CDC-funded multicenter research consortium in medical toxicology. Among Dr. Brent’s accomplishments are career achievement awards from the American Academy of Clinical Toxicology, The American College of Medical Toxicology, The European Association of Clinical Toxicologists and Poisons Centres, and the Society of Toxicology. He has over 200 peer-reviewed publications and is the Senior Editor for the textbook Critical Care Toxicology – The Diagnosis and Management of the Critically Poisoned Patient, now in its second edition.

Accreditation & Credit Designation Statements

Joint Accreditation Statement
image

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The American Society of Addiction Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

This activity awards 1.25 Nursing contact hours.

image
PAs

ASAM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 05/06/2027.  PAs should only claim credit commensurate with the extent of their participation.

Social Workers

As a Jointly Accredited Organization, ASAM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.25 general continuing education credits.

IPCE Credit

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

Continuing Education Credits (CEUs)

Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.

Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)

This activity meets the requirements for MOC/CCP for the following primary physician boards and for state licensing CME requirements. MOC Credit is only reported for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

  • American Board of Medical Specialties (ABMS)
  • American Board of Preventive Medicine (ABPM)
  • American Board of Internal Medicine (ABIM)
  • American Board of Pediatrics (ABP)
  • American Board of Surgery (ABS)
  • American Board of Psychiatry and Neurology (ABPN)
  • American Board of Addiction Medicine (ABAM)
  • Royal College of Physicians and Surgeons of Canada (RCPSC)
    • Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons in Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Information

In accordance with disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed all financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. Click here to view the full disclosure listing.

Key:

Complete
Failed
Available
Locked
View On-Demand Recording
Open to view video.
Open to view video. Video is approximately 75 minutes long. Recorded between 04/04/24 - 04/07/24.
Complete Post Test
5 Questions  |  10 attempts  |  4/5 points to pass
5 Questions  |  10 attempts  |  4/5 points to pass This post-test has 5 questions and requires 4 out of 5 to pass the quiz.
Complete Evaluation
15 Questions
15 Questions Scroll down on evaluation, there may be questions that expand past the size of the window.
Claim Credit & Certificate
Up to 1.25 medical credits available  |  Certificate available
Up to 1.25 medical credits available  |  Certificate available Attendees should claim only the credit commensurate with the extent of their participation in the activity.